RevolKa.

RevolKa Ltd. is a biotechnology company utilizing an AI-driven protein engineering platform, ai Protein®, to create novel therapeutics. Their technology accelerates protein evolution, enabling the development of high-performance proteins for pharmaceutical and industrial applications. This has led to positive in vitro proof-of-concept for drug candidates targeting rare diseases.

Buy Funded Startups lists

Funding Round: Series A+

Funding Amount: $1.7M

Date: 29-Aug-2024

Investors: D3 LLC, DEEPCORE Inc., Tohoku University Venture Partners Co., Ltd., SBI Investment Co., Ltd.

Markets: Biotechnology, Pharmaceuticals, AI

HQ: Tokyo, Tokyo, Japan

Founded: 2021

Website: https://www.revolka.com/en/

LinkedIn: https://www.linkedin.com/company/revolka-ltd

Twitter:

Instagram: